Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Meloxicam vs Usual Care NSAIDs in Osteoarthritis
NCT02183064Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Oct 1998
- Primary completion
- Nov 2000
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of meloxicam in osteoarthritis (OA), sponsored by Boehringer Ingelheim. Started Oct 1998; status: completed.
02
Drugs
meloxicam
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT02183064.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02183064.